Literature DB >> 19771440

Definitive chemotherapy: a new frontier in the fight against laryngeal cancer.

Missak Haigentz, Carl E Silver, Alessandra Rinaldo, Alfio Ferlito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19771440      PMCID： PMC7103171          DOI： 10.1007/s00405-009-1105-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  12 in total

1.  Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma.

Authors:  C R Bradford; G T Wolf; T E Carey; S Zhu; T F Beals; J M Truelson; K D McClatchey; S G Fisher
Journal:  Otolaryngol Head Neck Surg       Date:  1999-11       Impact factor: 3.497

2.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

3.  Chemotherapy alone for laryngeal preservation--is it possible?

Authors:  Arlene A Forastiere; Ashok R Shaha
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

4.  Analysis of local recurrence in patients with selected T1-3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure.

Authors:  Ollivier Laccourreye; David Veivers; Vincent Bassot; Madeleine Ménard; Daniel Brasnu; Henri Laccourreye
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-04       Impact factor: 1.547

5.  Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.

Authors:  O Laccourreye; D Brasnu; V Bassot; M Ménard; D Khayat; H Laccourreye
Journal:  J Clin Oncol       Date:  1996-08       Impact factor: 44.544

6.  Chemotherapy alone in laryngeal squamous cell carcinoma.

Authors:  P Bonfils; J Trotoux; V Bassot
Journal:  J Laryngol Otol       Date:  2006-09-28       Impact factor: 1.469

Review 7.  Current trends in initial management of laryngeal cancer: the declining use of open surgery.

Authors:  Carl E Silver; Jonathan J Beitler; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

8.  Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.

Authors:  Jean-Louis Lefebvre; K Kian Ang
Journal:  Head Neck       Date:  2009-04       Impact factor: 3.147

9.  Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.

Authors:  F Christopher Holsinger; Merrill S Kies; Eduardo M Diaz; Ann M Gillenwater; Jan S Lewin; Lawrence E Ginsberg; Bonnie S Glisson; Adam S Garden; Nebil Ark; Heather Y Lin; J Jack Lee; Adel K El-Naggar; Waun Ki Hong; Dong M Shin; Fadlo R Khuri
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

10.  Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx.

Authors:  F Christopher Holsinger; Heather Y Lin; Vincent Bassot; Ollivier Laccourreye
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860
View more
  3 in total

1.  When is chemotherapy in head and neck squamous cell carcinoma not indicated?

Authors:  Missak Haigentz; Jan B Vermorken; Arlene A Forastiere; June Corry; Jonathan J Beitler; Primož Strojan; Dana M Hartl; Juan P Rodrigo; Carol R Bradford; Alessandra Rinaldo; Robert P Takes; William M Mendenhall; Ashok R Shaha; Gregory T Wolf; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-14       Impact factor: 2.503

Review 2.  Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond.

Authors:  Remco de Bree; Gregory T Wolf; Bart de Keizer; Iain J Nixon; Dana M Hartl; Arlene A Forastiere; Missak Haigentz; Alessandra Rinaldo; Juan P Rodrigo; Nabil F Saba; Carlos Suárez; Jan B Vermorken; Alfio Ferlito
Journal:  Head Neck       Date:  2017-08-17       Impact factor: 3.147

3.  Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells.

Authors:  Yachun Li; Dongjie Li; Ping Wang; Wei Zhu; Wanzhong Yin
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.